25 XP   0   0   10

Genetic Technologies Ltd
Buy, Hold or Sell?

Let's analyse Genetic Technologies Ltd together

PenkeI guess you are interested in Genetic Technologies Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Genetic Technologies Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Genetic Technologies Ltd

I send you an email if I find something interesting about Genetic Technologies Ltd.

Quick analysis of Genetic Technologies Ltd (30 sec.)










What can you expect buying and holding a share of Genetic Technologies Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.10
Expected worth in 1 year
A$0.48
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
A$0.38
Return On Investment
217.0%

For what price can you sell your share?

Current Price per Share
A$0.18
Expected price per share
A$0.15 - A$0.2
How sure are you?
50%

1. Valuation of Genetic Technologies Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.18

Intrinsic Value Per Share

A$-0.82 - A$-0.46

Total Value Per Share

A$-0.72 - A$-0.36

2. Growth of Genetic Technologies Ltd (5 min.)




Is Genetic Technologies Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$7.2m$10.6m-$3.4m-47.2%

How much money is Genetic Technologies Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$7.5m-$4.6m-$2.9m-39.3%
Net Profit Margin-113.6%-104.9%--

How much money comes from the company's main activities?

3. Financial Health of Genetic Technologies Ltd (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#114 / 146

Most Revenue
#110 / 146

Most Profit
#98 / 146

Most Efficient
#112 / 146

What can you expect buying and holding a share of Genetic Technologies Ltd? (5 min.)

Welcome investor! Genetic Technologies Ltd's management wants to use your money to grow the business. In return you get a share of Genetic Technologies Ltd.

What can you expect buying and holding a share of Genetic Technologies Ltd?

First you should know what it really means to hold a share of Genetic Technologies Ltd. And how you can make/lose money.

Speculation

The Price per Share of Genetic Technologies Ltd is A$0.175. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genetic Technologies Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genetic Technologies Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.10. Based on the TTM, the Book Value Change Per Share is A$0.09 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genetic Technologies Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.07-37.6%-0.07-37.6%0.00-0.3%-0.02-11.7%-0.01-7.1%
Usd Book Value Change Per Share0.0635.1%0.0635.1%0.00-0.3%0.017.0%0.013.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.0635.1%0.0635.1%0.00-0.3%0.017.0%0.013.2%
Usd Price Per Share0.00-0.00-0.00-0.00-0.01-
Price to Earnings Ratio-0.02--0.02--3.88--3.34--3.34-
Price-to-Total Gains Ratio0.03-0.03--4.06--1.87--2.08-
Price to Book Ratio0.03-0.03-1.68-2.81-3.79-
Price-to-Total Gains Ratio0.03-0.03--4.06--1.87--2.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1131725
Number of shares8836
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.060.01
Usd Total Gains Per Share0.060.01
Gains per Quarter (8836 shares)542.47108.47
Gains per Year (8836 shares)2,169.88433.87
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10217021600434424
20434043300868858
3065106500013021292
4086808670017351726
501084910840021692160
601301913010026032594
701518915180030373028
801735917350034713462
901952919520039053896
1002169921690043394330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%1.023.00.04.2%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%10.014.00.041.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.024.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%10.014.00.041.7%

Fundamentals of Genetic Technologies Ltd

About Genetic Technologies Ltd

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.

Fundamental data was last updated by Penke on 2024-03-31 09:54:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Genetic Technologies Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Genetic Technologies Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -113.6% means that $-1.14 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genetic Technologies Ltd:

  • The MRQ is -113.6%. The company is making a huge loss. -2
  • The TTM is -113.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-113.6%TTM-113.6%0.0%
TTM-113.6%YOY-104.9%-8.6%
TTM-113.6%5Y-18,955.0%+18,841.4%
5Y-18,955.0%10Y-10,096.8%-8,858.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-113.6%-7.2%-106.4%
TTM-113.6%-5.3%-108.3%
YOY-104.9%0.9%-105.8%
5Y-18,955.0%-3.4%-18,951.6%
10Y-10,096.8%-1.4%-10,095.4%
1.1.2. Return on Assets

Shows how efficient Genetic Technologies Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • -79.1% Return on Assets means that Genetic Technologies Ltd generated $-0.79 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genetic Technologies Ltd:

  • The MRQ is -79.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -79.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-79.1%TTM-79.1%0.0%
TTM-79.1%YOY-34.3%-44.8%
TTM-79.1%5Y-78.5%-0.6%
5Y-78.5%10Y-80.7%+2.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-79.1%-1.8%-77.3%
TTM-79.1%-1.3%-77.8%
YOY-34.3%-0.4%-33.9%
5Y-78.5%-0.6%-77.9%
10Y-80.7%-1.3%-79.4%
1.1.3. Return on Equity

Shows how efficient Genetic Technologies Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • -105.3% Return on Equity means Genetic Technologies Ltd generated $-1.05 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genetic Technologies Ltd:

  • The MRQ is -105.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -105.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-105.3%TTM-105.3%0.0%
TTM-105.3%YOY-43.4%-61.9%
TTM-105.3%5Y-122.2%+16.9%
5Y-122.2%10Y-147.8%+25.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-105.3%-1.2%-104.1%
TTM-105.3%-0.1%-105.2%
YOY-43.4%0.4%-43.8%
5Y-122.2%-1.7%-120.5%
10Y-147.8%-2.5%-145.3%

1.2. Operating Efficiency of Genetic Technologies Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Genetic Technologies Ltd is operating .

  • Measures how much profit Genetic Technologies Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • An Operating Margin of -100.7% means the company generated $-1.01  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genetic Technologies Ltd:

  • The MRQ is -100.7%. The company is operating very inefficient. -2
  • The TTM is -100.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-100.7%TTM-100.7%0.0%
TTM-100.7%YOY-63.2%-37.5%
TTM-100.7%5Y-18,299.4%+18,198.8%
5Y-18,299.4%10Y-9,773.9%-8,525.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-100.7%-4.3%-96.4%
TTM-100.7%-2.3%-98.4%
YOY-63.2%4.8%-68.0%
5Y-18,299.4%2.3%-18,301.7%
10Y-9,773.9%-1.3%-9,772.6%
1.2.2. Operating Ratio

Measures how efficient Genetic Technologies Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 2.17 means that the operating costs are $2.17 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Genetic Technologies Ltd:

  • The MRQ is 2.169. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.169. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.169TTM2.1690.000
TTM2.169YOY0.505+1.664
TTM2.1695Y188.798-186.628
5Y188.79810Y101.323+87.474
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1691.302+0.867
TTM2.1691.300+0.869
YOY0.5051.236-0.731
5Y188.7981.261+187.537
10Y101.3231.238+100.085

1.3. Liquidity of Genetic Technologies Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Genetic Technologies Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 3.17 means the company has $3.17 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Genetic Technologies Ltd:

  • The MRQ is 3.170. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.170. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.170TTM3.1700.000
TTM3.170YOY3.861-0.691
TTM3.1705Y7.173-4.003
5Y7.17310Y7.019+0.153
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1702.194+0.976
TTM3.1702.366+0.804
YOY3.8612.822+1.039
5Y7.1733.017+4.156
10Y7.0193.000+4.019
1.3.2. Quick Ratio

Measures if Genetic Technologies Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • A Quick Ratio of 2.44 means the company can pay off $2.44 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genetic Technologies Ltd:

  • The MRQ is 2.439. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.439. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.439TTM2.4390.000
TTM2.439YOY3.716-1.277
TTM2.4395Y6.809-4.370
5Y6.80910Y6.739+0.069
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4391.355+1.084
TTM2.4391.366+1.073
YOY3.7161.563+2.153
5Y6.8091.997+4.812
10Y6.7392.127+4.612

1.4. Solvency of Genetic Technologies Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Genetic Technologies Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genetic Technologies Ltd to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.25 means that Genetic Technologies Ltd assets are financed with 24.9% credit (debt) and the remaining percentage (100% - 24.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genetic Technologies Ltd:

  • The MRQ is 0.249. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.249. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.249TTM0.2490.000
TTM0.249YOY0.210+0.039
TTM0.2495Y0.217+0.032
5Y0.21710Y0.237-0.020
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2490.425-0.176
TTM0.2490.416-0.167
YOY0.2100.393-0.183
5Y0.2170.450-0.233
10Y0.2370.448-0.211
1.4.2. Debt to Equity Ratio

Measures if Genetic Technologies Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 33.1% means that company has $0.33 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genetic Technologies Ltd:

  • The MRQ is 0.331. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.331. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.331TTM0.3310.000
TTM0.331YOY0.266+0.065
TTM0.3315Y0.325+0.006
5Y0.32510Y0.497-0.172
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3310.606-0.275
TTM0.3310.574-0.243
YOY0.2660.603-0.337
5Y0.3250.648-0.323
10Y0.4970.730-0.233

2. Market Valuation of Genetic Technologies Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Genetic Technologies Ltd generates.

  • Above 15 is considered overpriced but always compare Genetic Technologies Ltd to the Diagnostics & Research industry mean.
  • A PE ratio of -0.02 means the investor is paying $-0.02 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genetic Technologies Ltd:

  • The EOD is -1.719. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.025. Based on the earnings, the company is expensive. -2
  • The TTM is -0.025. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.719MRQ-0.025-1.694
MRQ-0.025TTM-0.0250.000
TTM-0.025YOY-3.879+3.854
TTM-0.0255Y-3.344+3.320
5Y-3.34410Y-3.336-0.008
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.719-0.295-1.424
MRQ-0.025-0.518+0.493
TTM-0.025-0.156+0.131
YOY-3.879-0.003-3.876
5Y-3.3441.627-4.971
10Y-3.3366.427-9.763
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genetic Technologies Ltd:

  • The EOD is -2.074. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.030. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.030. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.074MRQ-0.030-2.044
MRQ-0.030TTM-0.0300.000
TTM-0.030YOY-4.805+4.776
TTM-0.0305Y-3.597+3.567
5Y-3.59710Y-3.450-0.148
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-2.074-0.284-1.790
MRQ-0.030-0.382+0.352
TTM-0.030-1.074+1.044
YOY-4.805-2.055-2.750
5Y-3.597-2.492-1.105
10Y-3.450-2.411-1.039
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Genetic Technologies Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 0.03 means the investor is paying $0.03 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Genetic Technologies Ltd:

  • The EOD is 1.809. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.026. Based on the equity, the company is cheap. +2
  • The TTM is 0.026. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.809MRQ0.026+1.784
MRQ0.026TTM0.0260.000
TTM0.026YOY1.683-1.658
TTM0.0265Y2.810-2.784
5Y2.81010Y3.786-0.975
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.8091.960-0.151
MRQ0.0262.449-2.423
TTM0.0262.225-2.199
YOY1.6833.239-1.556
5Y2.8103.393-0.583
10Y3.7863.897-0.111
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Genetic Technologies Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Genetic Technologies Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0950.0950%-0.001+101%0.019+400%0.009+1013%
Book Value Per Share--0.0970.0970%0.002+5327%0.045+117%0.026+279%
Current Ratio--3.1703.1700%3.861-18%7.173-56%7.019-55%
Debt To Asset Ratio--0.2490.2490%0.210+18%0.217+15%0.237+5%
Debt To Equity Ratio--0.3310.3310%0.266+24%0.325+2%0.497-33%
Dividend Per Share----0%-0%-0%-0%
Eps---0.102-0.1020%-0.001-99%-0.032-69%-0.019-81%
Free Cash Flow Per Share---0.084-0.0840%-0.001-99%-0.028-67%-0.017-79%
Free Cash Flow To Equity Per Share---0.033-0.0330%-0.001-98%0.015-320%0.008-507%
Gross Profit Margin--1.2511.2510%1.264-1%1.172+7%1.289-3%
Intrinsic Value_10Y_max---0.460--------
Intrinsic Value_10Y_min---0.819--------
Intrinsic Value_1Y_max---0.024--------
Intrinsic Value_1Y_min---0.043--------
Intrinsic Value_3Y_max---0.088--------
Intrinsic Value_3Y_min---0.163--------
Intrinsic Value_5Y_max---0.173--------
Intrinsic Value_5Y_min---0.320--------
Market Cap20197975.000+99%288542.500288542.5000%27661044.843-99%23392948.877-99%24823187.691-99%
Net Profit Margin---1.136-1.1360%-1.049-8%-189.550+16592%-100.968+8791%
Operating Margin---1.007-1.0070%-0.632-37%-182.994+18079%-97.739+9610%
Operating Ratio--2.1692.1690%0.505+330%188.798-99%101.323-98%
Pb Ratio1.809+99%0.0260.0260%1.683-98%2.810-99%3.786-99%
Pe Ratio-1.719-6900%-0.025-0.0250%-3.879+15697%-3.344+13519%-3.336+13485%
Price Per Share0.175+99%0.0030.0030%0.003-17%0.005-50%0.013-80%
Price To Free Cash Flow Ratio-2.074-6900%-0.030-0.0300%-4.805+16122%-3.597+12043%-3.450+11545%
Price To Total Gains Ratio1.843+99%0.0260.0260%-4.064+15533%-1.872+7209%-2.084+8012%
Quick Ratio--2.4392.4390%3.716-34%6.809-64%6.739-64%
Return On Assets---0.791-0.7910%-0.343-57%-0.785-1%-0.807+2%
Return On Equity---1.053-1.0530%-0.434-59%-1.222+16%-1.478+40%
Total Gains Per Share--0.0950.0950%-0.001+101%0.019+400%0.009+1013%
Usd Book Value--7218837.8997218837.8990%10625973.616-32%8392936.623-14%7298098.292-1%
Usd Book Value Change Per Share--0.0610.0610%0.000+101%0.012+400%0.006+1013%
Usd Book Value Per Share--0.0630.0630%0.001+5327%0.029+117%0.017+279%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.066-0.0660%-0.001-99%-0.021-69%-0.012-81%
Usd Free Cash Flow---6299276.415-6299276.4150%-3722566.875-41%-4437463.330-30%-4910398.144-22%
Usd Free Cash Flow Per Share---0.055-0.0550%0.000-99%-0.018-67%-0.011-79%
Usd Free Cash Flow To Equity Per Share---0.021-0.0210%0.000-98%0.010-320%0.005-507%
Usd Market Cap13062030.433+99%186600.435186600.4350%17888397.700-99%15128220.039-99%16053155.480-99%
Usd Price Per Share0.113+99%0.0020.0020%0.002-17%0.003-50%0.008-80%
Usd Profit---7599321.904-7599321.9040%-4611616.407-39%-5030233.853-34%-5183532.407-32%
Usd Revenue--6691990.8106691990.8100%4394207.507+52%2237398.855+199%1643078.968+307%
Usd Total Gains Per Share--0.0610.0610%0.000+101%0.012+400%0.006+1013%
 EOD+6 -2MRQTTM+0 -0YOY+10 -245Y+15 -1910Y+16 -18

4.2. Fundamental Score

Let's check the fundamental score of Genetic Technologies Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.719
Price to Book Ratio (EOD)Between0-11.809
Net Profit Margin (MRQ)Greater than0-1.136
Operating Margin (MRQ)Greater than0-1.007
Quick Ratio (MRQ)Greater than12.439
Current Ratio (MRQ)Greater than13.170
Debt to Asset Ratio (MRQ)Less than10.249
Debt to Equity Ratio (MRQ)Less than10.331
Return on Equity (MRQ)Greater than0.15-1.053
Return on Assets (MRQ)Greater than0.05-0.791
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Genetic Technologies Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.553
Ma 20Greater thanMa 500.142
Ma 50Greater thanMa 1000.126
Ma 100Greater thanMa 2000.150
OpenGreater thanClose0.165
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets14,856
Total Liabilities3,694
Total Stockholder Equity11,163
 As reported
Total Liabilities 3,694
Total Stockholder Equity+ 11,163
Total Assets = 14,856

Assets

Total Assets14,856
Total Current Assets10,498
Long-term Assets4,237
Total Current Assets
Cash And Cash Equivalents 7,851
Short-term Investments 17
Net Receivables 192
Inventory 326
Other Current Assets 2,111
Total Current Assets  (as reported)10,498
Total Current Assets  (calculated)10,498
+/- 0
Long-term Assets
Property Plant Equipment 599
Goodwill 3,117
Intangible Assets 520
Other Assets 122
Long-term Assets  (as reported)4,237
Long-term Assets  (calculated)4,358
+/- 122

Liabilities & Shareholders' Equity

Total Current Liabilities3,312
Long-term Liabilities382
Total Stockholder Equity11,163
Total Current Liabilities
Short-term Debt 304
Accounts payable 838
Other Current Liabilities 1,321
Total Current Liabilities  (as reported)3,312
Total Current Liabilities  (calculated)2,463
+/- 849
Long-term Liabilities
Long term Debt Total 229
Other Liabilities 152
Long-term Liabilities  (as reported)382
Long-term Liabilities  (calculated)382
+/- 0
Total Stockholder Equity
Common Stock161,343
Retained Earnings -156,716
Accumulated Other Comprehensive Income 6,536
Total Stockholder Equity (as reported)11,163
Total Stockholder Equity (calculated)11,163
+/-0
Other
Capital Stock161,343
Cash and Short Term Investments 7,869
Common Stock Shares Outstanding 101,381
Current Deferred Revenue849
Liabilities and Stockholders Equity 14,856
Net Debt -7,318
Net Invested Capital 11,163
Net Tangible Assets 7,525
Net Working Capital 7,186
Property Plant and Equipment Gross 1,815
Short Long Term Debt Total 533



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
> Total Assets 
8,847
39,686
33,001
30,245
22,389
29,264
22,442
20,952
24,146
17,978
8,280
8,922
16,442
8,320
6,729
20,720
13,290
12,108
6,166
3,265
15,633
22,972
20,802
14,856
14,85620,80222,97215,6333,2656,16612,10813,29020,7206,7298,32016,4428,9228,28017,97824,14620,95222,44229,26422,38930,24533,00139,6868,847
   > Total Current Assets 
5,402
3,382
8,245
7,373
12,964
19,675
13,092
13,651
15,928
10,103
4,502
6,255
9,950
2,657
4,361
19,566
12,131
11,632
5,991
3,196
15,193
22,236
14,717
10,498
10,49814,71722,23615,1933,1965,99111,63212,13119,5664,3612,6579,9506,2554,50210,10315,92813,65113,09219,67512,9647,3738,2453,3825,402
       Cash And Cash Equivalents 
1,229
646
7,160
5,829
11,299
17,658
11,102
12,460
12,949
7,827
3,306
5,105
8,900
1,721
2,831
18,341
11,180
10,988
5,487
2,132
14,214
20,902
11,731
7,851
7,85111,73120,90214,2142,1325,48710,98811,18018,3412,8311,7218,9005,1053,3067,82712,94912,46011,10217,65811,2995,8297,1606461,229
       Short-term Investments 
0
0
70
0
38
88
0
77
0
0
72
2
17
209
3
4
4
3
4
53
2
2
13
17
17132253434432091727200770883807000
       Net Receivables 
89
191
233
1,237
1,627
1,191
1,401
647
1,600
1,829
755
674
496
329
1,112
715
631
426
301
819
39
1,074
2,421
192
1922,4211,074398193014266317151,1123294966747551,8291,6006471,4011,1911,6271,23723319189
       Inventory 
4,083
2,458
782
258
0
0
0
0
262
302
256
283
317
214
213
317
167
77
59
32
91
77
398
326
326398779132597716731721321431728325630226200002587822,4584,083
   > Long-term Assets 
3,445
36,304
24,756
22,872
9,425
9,589
9,350
7,301
8,218
7,875
3,777
2,667
6,492
5,662
2,369
1,154
1,159
477
175
69
440
736
6,085
4,237
4,2376,085736440691754771,1591,1542,3695,6626,4922,6673,7777,8758,2187,3019,3509,5899,42522,87224,75636,3043,445
       Property Plant Equipment 
334
801
492
1,490
1,841
2,604
2,267
1,946
1,707
3,010
1,978
948
643
423
394
418
550
477
175
69
440
638
953
599
599953638440691754775504183944236439481,9783,0101,7071,9462,2672,6041,8411,490492801334
       Goodwill 
0
24,509
405
437
413
389
346
346
316
1,582
318
315
315
315
315
0
0
0
0
0
0
4,507
4,507
3,117
3,1174,5074,5070000003153153153153181,58231634634638941343740524,5090
       Intangible Assets 
0
27,364
23,985
20,632
6,862
6,246
5,148
3,349
5,987
5,712
1,482
1,404
1,119
991
864
736
608
0
0
0
0
5,132
625
520
5206255,13200006087368649911,1191,4041,4825,7125,9873,3495,1486,2466,86220,63223,98527,3640
       Long-term Assets Other 
3,112
8,140
279
750
722
740
1,589
1,658
208
0
0
0
0
0
0
0
0
0
175
69
-440
-9,540
-6,085
-4,237
-4,237-6,085-9,540-440691750000000002081,6581,5897407227502798,1403,112
> Total Liabilities 
1,270
1,618
1,865
2,968
5,321
6,510
4,176
4,051
3,317
3,866
2,562
2,108
2,039
2,561
4,902
1,760
1,406
1,529
1,454
1,494
1,640
1,439
4,371
3,694
3,6944,3711,4391,6401,4941,4541,5291,4061,7604,9022,5612,0392,1082,5623,8663,3174,0514,1766,5105,3212,9681,8651,6181,270
   > Total Current Liabilities 
1,270
1,618
1,865
2,968
4,624
4,903
2,947
3,252
3,054
3,779
2,479
2,026
1,931
2,465
2,318
1,735
1,332
1,465
1,451
1,493
1,398
1,405
3,812
3,312
3,3123,8121,4051,3981,4931,4511,4651,3321,7352,3182,4651,9312,0262,4793,7793,0543,2522,9474,9034,6242,9681,8651,6181,270
       Short-term Debt 
0
0
0
0
38
0
491
478
111
373
383
68
18
209
3
25
4
3
4
241
241
180
264
304
30426418024124143425320918683833731114784910380000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,502
25
0
0
0
0
0
0
0
0
00000000252,50200000000000000
       Accounts payable 
385
446
717
1,978
2,501
2,582
905
853
1,292
1,624
680
653
333
622
900
517
392
398
536
590
350
270
1,154
838
8381,1542703505905363983925179006223336536801,6241,2928539052,5822,5011,978717446385
       Other Current Liabilities 
1,270
1,618
1,865
2,968
1,958
1,420
1,012
888
1,013
1,018
706
679
1,314
1,522
1,265
1,116
940
1,067
915
903
1,047
955
1,580
1,321
1,3211,5809551,0479039151,0679401,1161,2651,5221,3146797061,0181,0138881,0121,4201,9582,9681,8651,6181,270
   > Long-term Liabilities 
0
0
0
0
696
1,607
1,229
798
263
86
83
83
109
96
2,584
25
74
64
3
1
52
33
559
382
3825593352136474252,584961098383862637981,2291,6076960000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
241
24
388
229
2293882424100000000000000000000
       Other Liabilities 
0
0
0
0
0
0
37
50
75
86
83
83
109
96
81
25
74
64
3
1
979
9
171
152
1521719979136474258196109838386755037000000
> Total Stockholder Equity
7,577
38,068
31,136
27,277
16,951
22,590
18,091
16,756
20,688
13,957
5,533
6,612
14,248
5,638
1,828
18,959
11,883
10,579
4,712
1,771
13,993
21,533
16,431
11,163
11,16316,43121,53313,9931,7714,71210,57911,88318,9591,8285,63814,2486,6125,53313,95720,68816,75618,09122,59016,95127,27731,13638,0687,577
   Common Stock
20,212
53,957
39,351
39,684
24,732
36,164
37,993
70,244
70,244
71,286
72,378
72,378
83,280
83,736
90,080
115,247
115,273
122,383
122,373
125,499
140,111
153,575
155,139
161,343
161,343155,139153,575140,111125,499122,373122,383115,273115,24790,08083,73683,28072,37872,37871,28670,24470,24437,99336,16424,73239,68439,35153,95720,212
   Retained Earnings -156,716-150,206-143,075-136,047-129,738-123,312-117,848-109,444-100,985-92,175-82,050-72,752-67,464-68,374-57,328-51,299-21,712-22,913-17,026-10,354-12,293-8,243-17,907-14,517
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
1,882
2,018
28
0
0
0
0
0
0
0
0
0
0
0
3,922
4,697
1,420
6,044
5,651
6,010
1,173
-10,500
-4,932
-4,627
-4,627-4,932-10,5001,1736,0105,6516,0441,4204,6973,92200000000000282,0181,882



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.